We report that SP600125 inhibited FAO, synergistically enhanced the cytotoxic effect of tamoxifen and reversed tamoxifen resistance in ER-positive BC cells, providing a new idea explaining how JNK inhibitors exert anticancer effects. The gene discussed is ESR1; the disease is breast cancer.